Search results
Results from the WOW.Com Content Network
Codeine/paracetamol, also called codeine/acetaminophen and co-codamol, is a compound analgesic, comprising codeine phosphate and paracetamol (acetaminophen). Codeine/paracetamol is used for the relief of mild to moderate pain when paracetamol or non-steroidal anti-inflammatory drugs (NSAIDs; such as ibuprofen, aspirin, and naproxen) alone do not sufficiently relieve symptoms.
Codeine is marketed as both a single-ingredient drug and in combination preparations with paracetamol (as co-codamol: e.g., brands Paracod, Panadeine, and the Tylenol-with-codeine series, including Tylenol 3 and 1, 2, and 4); with aspirin (as co-codaprin); or with ibuprofen (as Nurofen Plus).
If you take three or even four once you will be ok, as long as you take no more than 8 in 24 hours202.161.5.252 08:11, ... "Co-Codamol" is paracetamol + codeine ...
[7] [8] It is not available in the United Kingdom, [9] though the combination codeine/paracetamol (co-codamol) is. [10] It is sold under the brand names Vicodin and Norco among others. [ 1 ] [ 2 ]
Co-dydramol is a non-proprietary name used to denote a particular compound analgesic, a combination of dihydrocodeine tartrate and paracetamol. Co-dydramol tablets are used for the relief of moderate pain. Co-dydramol is part of a series of combination drugs available in the UK and other countries including co-codaprin (aspirin and codeine).
Therefore, one could extract all 256mg of Codeine Phosphate in a standard 8/500mg Co-codamol pack of 32 in a comparatively tiny amount of liquid. Even if the user starts the CWE process with 50ml water, (which, theoretically could hold 200g codeine phosphate), the maximum amount of paracetamol consumed will be 450mg (50ml*9mg/ml=450mg), which ...
Those who take it regularly at a higher dose (more than 2–3 g daily) are at much higher risk (3.6–3.7 times) of gastrointestinal bleeding and other bleeding events. [82] Meta-analyses suggest that paracetamol may increase the risk of kidney impairment by 23 % [ 83 ] and kidney cancer by 28 %. [ 81 ]
Approved indication for dihydrocodeine is the management of moderate to moderately severe pain as well as coughing and shortness of breath. As is the case with other drugs in this group, the antitussive dose tends to be less than the analgesic dose, and dihydrocodeine is a powerful cough suppressant like all other members of the immediate codeine family (see below) and their cousins ...